Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.95 +0.08 (+4.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026)

Updated

Polaryx Therapeutics' Research & Development came in at $719,000 for Q2 2026, up 51.1% from $476,000 a year earlier and up 5.9% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Research & Development (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Polaryx Therapeutics reported Research & Development of $6.59 million; for FY2025, it came in at $6.27 million, up 122.9% from FY2024.

  • Going back by year, Research & Development was $2.81 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 4.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.57 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.61 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.02 Bn
10 Polaryx Therapeutics 93.21 Mn 68.83 Mn - 719,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 719,000.00
Mar 31, 2026 679,000.00
Jun 30, 2025 476,000.00
Mar 31, 2025 4.72 Mn
API Access

Polaryx Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PLYX&period=max&api_key=YOUR_API_KEY